Enliven Therapeutics Inc
(ELVN)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2001 | 12-2000 | 09-2000 | 06-2000 | 03-2000 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 130 | -26,740 | -23,380 | -9,220 | -5,400 |
| Depreciation Amortization | 1,070 | 6,800 | 5,630 | 4,080 | 1,890 |
| Other Working Capital | -1,450 | 7,840 | 3,220 | -1,240 | 530 |
| Other Operating Activity | -510 | 1,780 | 4,800 | 10 | 10 |
| Operating Cash Flow | $-760 | $-10,320 | $-9,730 | $-6,370 | $-2,970 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -450 | -4,050 | -3,580 | -3,030 | -1,420 |
| Other Investing Activity | 1,990 | 7,490 | 7,310 | 5,620 | 1,210 |
| Investing Cash Flow | $1,540 | $3,440 | $3,730 | $2,590 | $-210 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 170 | 1,910 | 1,530 | 1,380 | 990 |
| Financing Cash Flow | $170 | $1,910 | $1,530 | $1,380 | $990 |
| Beginning Cash Position | 4,210 | 9,180 | 9,180 | 9,180 | 9,180 |
| End Cash Position | 5,170 | 4,210 | 4,720 | 6,780 | 6,980 |
| Net Cash Flow | $950 | $-4,960 | $-4,460 | $-2,400 | $-2,200 |
| Free Cash Flow | |||||
| Operating Cash Flow | -760 | -10,320 | -9,730 | -6,370 | -2,970 |
| Free Cash Flow | -760 | -10,320 | -9,730 | -6,370 | -2,970 |